WINDTREE THERAPEUTICS INC /DE/ Cash and Equivalents

Quick Answer

WINDTREE THERAPEUTICS INC /DE/ reported Cash and Equivalents of $1.78 million for fiscal year 2024.

WINDTREE THERAPEUTICS INC /DE/ Cash and Equivalents — Annual History

Fiscal Year Cash and Equivalents YoY Change
2024 $1.78M -58.8%
2023 $4.32M -30.0%
2022 $6.17M -72.4%
2021 $22.35M +32.0%
2020 $16.93M -25.0%
2019 $22.58M +101.8%
2018 $11.19M +516.4%
2017 $1.81M -67.5%
2016 $5.59M -85.6%
2016 $38.72M +0.0%
2015 $38.72M -13.4%
2014 $44.71M -48.2%
2013 $86.28M +220.9%
2012 $26.89M +163.9%
2011 $10.19M -0.2%
2010 $10.21M -35.1%
2009 $15.74M

Quarterly Cash and Equivalents

Quarter Ending Cash and Equivalents YoY QoQ
September 30, 2025 $204.0K -91.1% -32.2%
June 30, 2025 $301.0K -83.3% -74.3%
March 31, 2025 $1.17M -53.9% -34.1%
December 31, 2024 $1.78M -58.8% -22.7%
September 30, 2024 $2.30M -68.8% +27.6%
June 30, 2024 $1.80M -84.3% -29.2%
March 31, 2024 $2.55M -39.9% -41.0%
December 31, 2023 $4.32M -30.0% -41.4%
  • WINDTREE THERAPEUTICS INC /DE/ showed a decrease of -58.8% in Cash and Equivalents compared to the prior fiscal year.
  • Over the 2009–2024 period, WINDTREE THERAPEUTICS INC /DE/’s cash and equivalents has declined by 88.7% (from $15.74 million to $1.78 million).
  • The most recent figure is from WINDTREE THERAPEUTICS INC /DE/’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 15, 2025.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment